AUS
NZ
UK
CA
USA
IND
Headlines
- Roku and Micron: Significant analyst adjustments with Roku upgraded and Micron downgraded.
- Top Upgrades: Bill, PotlatchDeltic, Champions Oncology, and Diageo see notable revisions in their market positions.
- Notable Downgrades: Micron Technology faces a major downgrade, alongside Interpublic Group and Simon Property.
The latest updates from Wall Street offer insights into significant research calls impacting the market. Here's a summary of today's key analyst updates:
Key Upgrades:
- Wolfe Research has elevated Roku (NASDAQ:ROKU) to Outperform from Peer Perform, setting a target of $93. The firm notes that Roku’s increased focus on monetization in response to concerns about connected TV ad sales suggests accelerated profitability.
- Exane BNP Paribas has upgraded Bill (NYSE:BILL) to Outperform from Neutral, with a target of $90. The firm highlights the company's investments in suppliers’ go-to-market strategies, which are expected to lead to sustainable growth.
- BofA has raised its stance on PotlatchDeltic (NASDAQ:PCH) to a more favorable position from Neutral, setting a target of $51. Despite short-term challenges, PotlatchDeltic presents substantial potential based on the firm's projections.
- Craig-Hallum has updated Champions Oncology (NASDAQ:CSBR) to a more favorable position from Hold, maintaining a price target of $6. Recent results show significant improvement, with revenue up 12% year-over-year and notable gains in adjusted EBITDA and EPS.
- BofA has adjusted its position on Diageo (NYSE:DEO) to a more favorable outlook from Neutral, increasing the target to 2,800 GBp from 2,600 GBp, citing improved forecasts after a challenging period.
Noteworthy Downgrades:
- Exane BNP Paribas has downgraded Micron Technology (NASDAQ:MU) from Outperform to Underperform, with a revised target of $67, down from $140. The firm anticipates a quicker-than-expected market correction due to oversupply issues in high bandwidth memory capacity.
